| 0 |
NEONATAL PNEUMOTHORAX |
18 |
0.3273 |
| 1 |
PULMONARY HAEMORRHAGE NEONATAL |
28 |
0.3043 |
| 2 |
NEONATAL HYPOXIA |
121 |
0.1463 |
| 3 |
RESPIRATORY TRACT HAEMORRHAGE NEONATAL |
1 |
0.1429 |
| 4 |
NEONATAL INTESTINAL PERFORATION |
5 |
0.1389 |
| 5 |
PANTOEA AGGLOMERANS TEST POSITIVE |
1 |
0.1250 |
| 6 |
CARDIO-RESPIRATORY ARREST NEONATAL |
9 |
0.1154 |
| 7 |
ENDOTRACHEAL INTUBATION COMPLICATION |
39 |
0.0661 |
| 8 |
END-TIDAL CO2 DECREASED |
3 |
0.0638 |
| 9 |
HAEMORRHAGE NEONATAL |
3 |
0.0577 |
| 10 |
NEONATAL RESPIRATORY FAILURE |
28 |
0.0553 |
| 11 |
MENINGITIS NEONATAL |
3 |
0.0545 |
| 12 |
NEONATAL PNEUMONIA |
12 |
0.0511 |
| 13 |
BRONCHITIS PNEUMOCOCCAL |
1 |
0.0476 |
| 14 |
LISTERIA TEST POSITIVE |
1 |
0.0455 |
| 15 |
LATE METABOLIC ACIDOSIS OF NEWBORN |
1 |
0.0417 |
| 16 |
BRADYCARDIA NEONATAL |
51 |
0.0405 |
| 17 |
MECONIUM PERITONITIS |
1 |
0.0400 |
| 18 |
CONGENITAL EMPHYSEMA |
1 |
0.0385 |
| 19 |
CYANOSIS NEONATAL |
24 |
0.0374 |
| 20 |
INFANTILE APNOEA |
30 |
0.0368 |
| 21 |
PREMATURE BABY DEATH |
3 |
0.0366 |
| 22 |
CARDIAC ARREST NEONATAL |
5 |
0.0362 |
| 23 |
DRUG-DEVICE INTERACTION |
4 |
0.0360 |
| 24 |
AIRWAY PEAK PRESSURE INCREASED |
5 |
0.0329 |
| 25 |
DISSEMINATED INTRAVASCULAR COAGULATION IN NEWBORN |
1 |
0.0323 |
| 26 |
NEONATAL ANURIA |
3 |
0.0316 |
| 27 |
INTRAVENTRICULAR HAEMORRHAGE NEONATAL |
15 |
0.0309 |
| 28 |
ENTERITIS NECROTICANS |
1 |
0.0278 |
| 29 |
BRONCHOPULMONARY DYSPLASIA |
20 |
0.0248 |
| 30 |
NECROTISING ENTEROCOLITIS NEONATAL |
10 |
0.0246 |
| 31 |
PULMONARY INTERSTITIAL EMPHYSEMA SYNDROME |
3 |
0.0211 |
| 32 |
TRACHEAL INJURY |
3 |
0.0204 |
| 33 |
RENAL FAILURE NEONATAL |
4 |
0.0180 |
| 34 |
HYPOXIC ISCHAEMIC ENCEPHALOPATHY NEONATAL |
1 |
0.0179 |
| 35 |
NEONATAL HEPATOMEGALY |
1 |
0.0179 |
| 36 |
BRONCHIAL INJURY |
1 |
0.0172 |
| 37 |
RENAL INTERSTITIAL FIBROSIS |
1 |
0.0169 |
| 38 |
DEATH NEONATAL |
23 |
0.0165 |
| 39 |
SEPSIS NEONATAL |
13 |
0.0160 |
| 40 |
CHEST WALL RIGIDITY |
1 |
0.0156 |
| 41 |
CENTRAL NERVOUS SYSTEM INJURY |
1 |
0.0154 |
| 42 |
CEREBRAL HAEMORRHAGE NEONATAL |
3 |
0.0142 |
| 43 |
PULMONARY PNEUMATOCELE |
1 |
0.0141 |
| 44 |
CYSTIC LUNG DISEASE |
2 |
0.0141 |
| 45 |
NEONATAL HYPOTENSION |
5 |
0.0136 |
| 46 |
MECHANICAL VENTILATION COMPLICATION |
2 |
0.0134 |
| 47 |
NEONATAL RESPIRATORY ACIDOSIS |
2 |
0.0132 |
| 48 |
PNEUMOPERICARDIUM |
2 |
0.0116 |
| 49 |
NEONATAL CARDIAC FAILURE |
1 |
0.0111 |
| 50 |
NEONATAL DYSPNOEA |
1 |
0.0105 |
| 51 |
PULMONARY HAEMORRHAGE |
78 |
0.0100 |
| 52 |
RENAL IMPAIRMENT NEONATAL |
1 |
0.0099 |
| 53 |
ATELECTASIS NEONATAL |
1 |
0.0093 |
| 54 |
VERTICAL INFECTION TRANSMISSION |
1 |
0.0088 |
| 55 |
INFANTILE APNOEIC ATTACK |
2 |
0.0085 |
| 56 |
NEONATAL ASPHYXIA |
6 |
0.0085 |
| 57 |
ANAEMIA NEONATAL |
4 |
0.0083 |
| 58 |
PRODUCT GEL FORMATION |
1 |
0.0082 |
| 59 |
NEONATAL HYPONATRAEMIA |
1 |
0.0082 |
| 60 |
BACILLUS INFECTION |
5 |
0.0079 |
| 61 |
THROMBOCYTOPENIA NEONATAL |
3 |
0.0071 |
| 62 |
PERIVENTRICULAR LEUKOMALACIA |
2 |
0.0071 |
| 63 |
HYPOTHERMIA NEONATAL |
1 |
0.0070 |
| 64 |
TRACHEAL OEDEMA |
1 |
0.0068 |
| 65 |
PULMONARY AIR LEAKAGE |
1 |
0.0066 |
| 66 |
PERSISTENT FOETAL CIRCULATION |
4 |
0.0066 |
| 67 |
NEONATAL TACHYCARDIA |
1 |
0.0065 |
| 68 |
IMMATURE RESPIRATORY SYSTEM |
1 |
0.0064 |
| 69 |
CONGENITAL GENITAL MALFORMATION |
1 |
0.0063 |
| 70 |
ULTRASOUND ABDOMEN ABNORMAL |
1 |
0.0062 |
| 71 |
OXYGEN SATURATION INCREASED |
2 |
0.0059 |
| 72 |
NEONATAL INFECTION |
2 |
0.0058 |
| 73 |
NEONATAL DISORDER |
9 |
0.0057 |
| 74 |
NEONATAL RESPIRATORY DISTRESS SYNDROME |
18 |
0.0051 |
| 75 |
MECONIUM ASPIRATION SYNDROME |
1 |
0.0047 |
| 76 |
NECROTISING COLITIS |
6 |
0.0047 |
| 77 |
RENAL CORTICAL NECROSIS |
1 |
0.0043 |
| 78 |
SUBCUTANEOUS EMPHYSEMA |
4 |
0.0041 |
| 79 |
DEPENDENCE ON OXYGEN THERAPY |
2 |
0.0041 |
| 80 |
NEONATAL SEIZURE |
1 |
0.0040 |
| 81 |
APNOEIC ATTACK |
2 |
0.0035 |
| 82 |
INTRAVENTRICULAR HAEMORRHAGE |
8 |
0.0032 |
| 83 |
NEONATAL RESPIRATORY DISTRESS |
3 |
0.0032 |
| 84 |
NEONATAL ASPIRATION |
1 |
0.0030 |
| 85 |
HYPERCAPNIA |
9 |
0.0030 |
| 86 |
PULMONARY NECROSIS |
1 |
0.0029 |
| 87 |
PNEUMONITIS CHEMICAL |
1 |
0.0029 |
| 88 |
WEANING FAILURE |
1 |
0.0027 |
| 89 |
CLONIC CONVULSION |
2 |
0.0027 |
| 90 |
MEDIASTINAL DISORDER |
1 |
0.0027 |
| 91 |
BRONCHOPLEURAL FISTULA |
1 |
0.0027 |
| 92 |
FOETAL GROWTH RETARDATION |
2 |
0.0026 |
| 93 |
NEONATAL TACHYPNOEA |
1 |
0.0024 |
| 94 |
RESUSCITATION |
4 |
0.0024 |
| 95 |
PNEUMOTHORAX |
37 |
0.0023 |
| 96 |
REFLUX LARYNGITIS |
1 |
0.0023 |
| 97 |
FEEDING INTOLERANCE |
1 |
0.0022 |
| 98 |
CENTRAL NERVOUS SYSTEM HAEMORRHAGE |
1 |
0.0021 |
| 99 |
JAUNDICE NEONATAL |
4 |
0.0021 |
| 100 |
OXYGEN CONSUMPTION INCREASED |
5 |
0.0021 |
| 101 |
RESPIRATORY DISORDER NEONATAL |
3 |
0.0018 |
| 102 |
INTERLEUKIN LEVEL INCREASED |
1 |
0.0018 |
| 103 |
ENDOTRACHEAL INTUBATION |
5 |
0.0018 |
| 104 |
RESPIRATORY TRACT HAEMORRHAGE |
1 |
0.0017 |
| 105 |
OXYGEN CONSUMPTION DECREASED |
1 |
0.0017 |
| 106 |
PNEUMOPERITONEUM |
3 |
0.0016 |
| 107 |
PRODUCT COMPLAINT |
40 |
0.0016 |
| 108 |
APGAR SCORE LOW |
2 |
0.0016 |
| 109 |
PNEUMONIA NECROTISING |
1 |
0.0015 |
| 110 |
ENTEROCOCCUS TEST POSITIVE |
1 |
0.0015 |
| 111 |
VULVAL DISORDER |
1 |
0.0015 |
| 112 |
ILEAL PERFORATION |
1 |
0.0015 |
| 113 |
CEREBRAL CYST |
1 |
0.0015 |
| 114 |
ANAEMIA MACROCYTIC |
3 |
0.0014 |
| 115 |
CATHETER SITE RELATED REACTION |
1 |
0.0013 |
| 116 |
COAGULATION TEST ABNORMAL |
1 |
0.0013 |
| 117 |
PRODUCT ADMINISTRATION ERROR |
26 |
0.0013 |
| 118 |
LABORATORY TEST INTERFERENCE |
1 |
0.0013 |
| 119 |
PULMONARY HYPOPLASIA |
1 |
0.0013 |
| 120 |
PLACENTAL INSUFFICIENCY |
1 |
0.0012 |
| 121 |
PERFORATION |
1 |
0.0012 |
| 122 |
HYPOGLYCAEMIA NEONATAL |
2 |
0.0012 |
| 123 |
BRADYCARDIA FOETAL |
1 |
0.0012 |
| 124 |
OESOPHAGEAL PERFORATION |
1 |
0.0012 |
| 125 |
OESOPHAGEAL RUPTURE |
1 |
0.0012 |
| 126 |
PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL |
1 |
0.0012 |
| 127 |
BRONCHIOLITIS |
4 |
0.0011 |
| 128 |
PNEUMOMEDIASTINUM |
2 |
0.0011 |
| 129 |
HEPATIC CONGESTION |
1 |
0.0011 |
| 130 |
AGITATION NEONATAL |
1 |
0.0010 |
| 131 |
PRESCRIBED OVERDOSE |
20 |
0.0010 |
| 132 |
DRUG ADMINISTERED IN WRONG DEVICE |
1 |
0.0010 |
| 133 |
PATENT DUCTUS ARTERIOSUS |
4 |
0.0010 |
| 134 |
SUSPECTED PRODUCT CONTAMINATION |
1 |
0.0010 |
| 135 |
CAPILLARY LEAK SYNDROME |
2 |
0.0010 |
| 136 |
HYPOPERFUSION |
1 |
0.0010 |
| 137 |
PRODUCT SELECTION ERROR |
1 |
0.0009 |
| 138 |
PULMONARY HYPERTENSION |
19 |
0.0009 |
| 139 |
CENTRAL NERVOUS SYSTEM INFECTION |
1 |
0.0009 |
| 140 |
HYPOCHLORAEMIA |
1 |
0.0009 |
| 141 |
ILL-DEFINED DISORDER |
50 |
0.0008 |
| 142 |
LIQUID PRODUCT PHYSICAL ISSUE |
6 |
0.0008 |
| 143 |
APNOEA |
6 |
0.0008 |
| 144 |
LUNG OPACITY |
2 |
0.0008 |
| 145 |
GLYCOSURIA |
1 |
0.0007 |
| 146 |
OFF LABEL USE OF DEVICE |
1 |
0.0007 |
| 147 |
CARBON DIOXIDE INCREASED |
1 |
0.0007 |
| 148 |
MUCOUS MEMBRANE DISORDER |
1 |
0.0007 |
| 149 |
RENAL INFARCT |
1 |
0.0007 |
| 150 |
BLOOD PRESSURE IMMEASURABLE |
1 |
0.0007 |
| 151 |
HYPERTROPHIC CARDIOMYOPATHY |
1 |
0.0006 |
| 152 |
BRONCHIAL DISORDER |
1 |
0.0006 |
| 153 |
PRODUCT DEPOSIT |
1 |
0.0006 |
| 154 |
HYPOTONIA NEONATAL |
1 |
0.0006 |
| 155 |
FUNGAEMIA |
1 |
0.0006 |
| 156 |
METABOLIC SYNDROME |
1 |
0.0006 |
| 157 |
BLOOD PH DECREASED |
1 |
0.0006 |
| 158 |
HYPOPROTEINAEMIA |
1 |
0.0005 |
| 159 |
ADRENAL DISORDER |
1 |
0.0005 |
| 160 |
CARDIOPULMONARY FAILURE |
2 |
0.0005 |
| 161 |
HYPERTRIGLYCERIDAEMIA |
3 |
0.0005 |
| 162 |
EMPYEMA |
1 |
0.0005 |
| 163 |
FOAMING AT MOUTH |
1 |
0.0005 |
| 164 |
HYPOSPADIAS |
1 |
0.0005 |
| 165 |
DILATATION VENTRICULAR |
1 |
0.0005 |
| 166 |
NOSOCOMIAL INFECTION |
1 |
0.0005 |
| 167 |
PRODUCT PACKAGE ASSOCIATED INJURY |
1 |
0.0004 |
| 168 |
CALCINOSIS |
1 |
0.0004 |
| 169 |
GASTROINTESTINAL HYPOMOTILITY |
1 |
0.0004 |
| 170 |
OXYGEN SATURATION DECREASED |
24 |
0.0004 |
| 171 |
DRUG ADMINISTRATION ERROR |
13 |
0.0004 |
| 172 |
DRUG EFFECT LESS THAN EXPECTED |
6 |
0.0004 |
| 173 |
EXCORIATION |
1 |
0.0004 |
| 174 |
INCREASED BRONCHIAL SECRETION |
1 |
0.0004 |
| 175 |
PRODUCT COLOUR ISSUE |
2 |
0.0004 |
| 176 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
2 |
0.0004 |
| 177 |
DISSEMINATED INTRAVASCULAR COAGULATION |
5 |
0.0004 |
| 178 |
OXYGEN SATURATION ABNORMAL |
1 |
0.0004 |
| 179 |
HAEMOTHORAX |
1 |
0.0003 |
| 180 |
PREMATURE BABY |
10 |
0.0003 |
| 181 |
NO THERAPEUTIC RESPONSE |
4 |
0.0003 |
| 182 |
ELECTROENCEPHALOGRAM ABNORMAL |
1 |
0.0003 |
| 183 |
SKIN INJURY |
1 |
0.0003 |
| 184 |
REGURGITATION |
1 |
0.0003 |
| 185 |
DEVICE OCCLUSION |
4 |
0.0003 |
| 186 |
PULMONARY ARTERIAL HYPERTENSION |
4 |
0.0003 |
| 187 |
INTESTINAL PERFORATION |
3 |
0.0003 |
| 188 |
SHOCK |
6 |
0.0003 |
| 189 |
TRICUSPID VALVE INCOMPETENCE |
2 |
0.0003 |
| 190 |
EXPOSURE VIA BREAST MILK |
1 |
0.0003 |
| 191 |
INCORRECT DRUG ADMINISTRATION RATE |
1 |
0.0002 |
| 192 |
CIRCULATORY COLLAPSE |
4 |
0.0002 |
| 193 |
POOR PERIPHERAL CIRCULATION |
1 |
0.0002 |
| 194 |
URINE OUTPUT DECREASED |
2 |
0.0002 |
| 195 |
PULMONARY FUNCTION TEST DECREASED |
1 |
0.0002 |
| 196 |
UNDERDOSE |
16 |
0.0002 |
| 197 |
METABOLIC ACIDOSIS |
7 |
0.0002 |
| 198 |
ISCHAEMIA |
1 |
0.0002 |
| 199 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
6 |
0.0002 |
| 200 |
BRONCHOSPASM |
3 |
0.0002 |
| 201 |
ACUTE RESPIRATORY FAILURE |
4 |
0.0002 |
| 202 |
RENAL TUBULAR NECROSIS |
2 |
0.0002 |
| 203 |
APPLICATION SITE BURN |
1 |
0.0002 |
| 204 |
STAPHYLOCOCCAL SEPSIS |
1 |
0.0002 |
| 205 |
EXPIRED DRUG ADMINISTERED |
1 |
0.0002 |
| 206 |
SMALL FOR DATES BABY |
1 |
0.0002 |
| 207 |
HYPERNATRAEMIA |
1 |
0.0002 |
| 208 |
PRODUCT QUALITY ISSUE |
27 |
0.0002 |
| 209 |
EMPHYSEMA |
2 |
0.0002 |
| 210 |
KLEBSIELLA INFECTION |
1 |
0.0002 |
| 211 |
DYSPHORIA |
1 |
0.0002 |
| 212 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
1 |
0.0002 |
| 213 |
DERMATITIS |
4 |
0.0002 |
| 214 |
HYDROCEPHALUS |
1 |
0.0002 |
| 215 |
ASPIRATION |
2 |
0.0002 |
| 216 |
COAGULOPATHY |
3 |
0.0002 |
| 217 |
OBSTRUCTIVE AIRWAYS DISORDER |
2 |
0.0002 |
| 218 |
HAEMOPTYSIS |
5 |
0.0002 |
| 219 |
ANGIOPATHY |
1 |
0.0002 |
| 220 |
VENTRICULAR SEPTAL DEFECT |
1 |
0.0002 |
| 221 |
METABOLIC DISORDER |
1 |
0.0002 |
| 222 |
RALES |
1 |
0.0002 |
| 223 |
ELECTROLYTE IMBALANCE |
2 |
0.0002 |
| 224 |
HEART RATE DECREASED |
6 |
0.0002 |
| 225 |
BRADYCARDIA |
9 |
0.0002 |
| 226 |
PROTHROMBIN TIME PROLONGED |
1 |
0.0002 |
| 227 |
FOETAL GROWTH RESTRICTION |
1 |
0.0002 |
| 228 |
PIGMENTATION DISORDER |
1 |
0.0002 |
| 229 |
OLIGURIA |
1 |
0.0002 |
| 230 |
BLOOD SODIUM DECREASED |
3 |
0.0002 |
| 231 |
APPLICATION SITE VESICLES |
1 |
0.0002 |
| 232 |
RESPIRATORY FAILURE |
11 |
0.0002 |
| 233 |
GENERAL PHYSICAL CONDITION ABNORMAL |
1 |
0.0001 |
| 234 |
TACHYPNOEA |
2 |
0.0001 |
| 235 |
PERITONITIS |
3 |
0.0001 |
| 236 |
CEREBRAL HAEMORRHAGE |
5 |
0.0001 |
| 237 |
HYPERGLYCAEMIA |
5 |
0.0001 |
| 238 |
ASCITES |
4 |
0.0001 |
| 239 |
HYPOPHOSPHATAEMIA |
1 |
0.0001 |
| 240 |
HAEMODYNAMIC INSTABILITY |
1 |
0.0001 |
| 241 |
ACIDOSIS |
1 |
0.0001 |
| 242 |
MATERNAL DRUGS AFFECTING FOETUS |
1 |
0.0001 |
| 243 |
PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 244 |
CYANOSIS |
2 |
0.0001 |
| 245 |
LOW BIRTH WEIGHT BABY |
1 |
0.0001 |
| 246 |
DRUG LEVEL INCREASED |
2 |
0.0001 |
| 247 |
EXPIRED PRODUCT ADMINISTERED |
4 |
0.0001 |
| 248 |
PSEUDOMONAS INFECTION |
1 |
0.0001 |
| 249 |
ANURIA |
1 |
0.0001 |
| 250 |
RASH GENERALISED |
3 |
0.0001 |
| 251 |
LUNG INFILTRATION |
1 |
0.0001 |
| 252 |
RESPIRATORY RATE INCREASED |
1 |
0.0001 |
| 253 |
PALLOR |
3 |
0.0001 |
| 254 |
HYPOTONIA |
1 |
0.0001 |
| 255 |
BRAIN INJURY |
1 |
0.0001 |
| 256 |
PERITONITIS BACTERIAL |
1 |
0.0001 |
| 257 |
HYPOTHERMIA |
1 |
0.0001 |
| 258 |
HYPERBILIRUBINAEMIA |
1 |
0.0001 |
| 259 |
OFF LABEL USE |
84 |
0.0001 |
| 260 |
TRANSFUSION |
1 |
0.0001 |
| 261 |
DRUG ADMINISTERED AT INAPPROPRIATE SITE |
1 |
0.0001 |
| 262 |
DECREASED ACTIVITY |
1 |
0.0001 |
| 263 |
PRODUCT DISPENSING ERROR |
2 |
0.0001 |
| 264 |
GENERAL PHYSICAL HEALTH DETERIORATION |
10 |
0.0001 |
| 265 |
FOETAL EXPOSURE DURING PREGNANCY |
7 |
0.0001 |
| 266 |
CAESAREAN SECTION |
1 |
0.0001 |
| 267 |
HYPOXIA |
3 |
0.0001 |
| 268 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
6 |
0.0001 |
| 269 |
C-REACTIVE PROTEIN INCREASED |
3 |
0.0001 |
| 270 |
RESPIRATORY DEPRESSION |
1 |
0.0001 |
| 271 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 272 |
ANAPHYLACTIC SHOCK |
2 |
0.0001 |
| 273 |
DEVICE DELIVERY SYSTEM ISSUE |
2 |
0.0001 |
| 274 |
PERIPHERAL COLDNESS |
1 |
0.0001 |
| 275 |
CARDIAC ARREST |
6 |
0.0001 |
| 276 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
13 |
0.0001 |
| 277 |
HYPOMAGNESAEMIA |
1 |
0.0001 |
| 278 |
CARDIO-RESPIRATORY ARREST |
3 |
0.0001 |
| 279 |
HAEMORRHAGE INTRACRANIAL |
1 |
0.0001 |
| 280 |
RESPIRATORY DISORDER |
2 |
0.0001 |
| 281 |
SKIN DISCOLOURATION |
3 |
0.0001 |
| 282 |
PREMATURE DELIVERY |
1 |
0.0001 |
| 283 |
BLOOD CREATININE INCREASED |
4 |
0.0001 |
| 284 |
LUNG DISORDER |
3 |
0.0001 |
| 285 |
LEUKOPENIA |
3 |
0.0001 |
| 286 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 287 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0001 |
| 288 |
DRUG EXPOSURE DURING PREGNANCY |
2 |
0.0001 |
| 289 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
0.0001 |
| 290 |
MULTI-ORGAN FAILURE |
1 |
0.0001 |
| 291 |
INTENTIONAL PRODUCT USE ISSUE |
5 |
0.0001 |
| 292 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
1 |
0.0001 |
| 293 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 294 |
HYPOCALCAEMIA |
1 |
0.0001 |
| 295 |
PULMONARY FIBROSIS |
1 |
0.0001 |
| 296 |
CHOLESTASIS |
1 |
0.0001 |
| 297 |
CHOKING |
1 |
0.0001 |
| 298 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 299 |
CARDIAC FAILURE |
4 |
0.0000 |
| 300 |
PRODUCT PHYSICAL ISSUE |
1 |
0.0000 |
| 301 |
RIB FRACTURE |
1 |
0.0000 |
| 302 |
ABDOMINAL DISTENSION |
5 |
0.0000 |
| 303 |
OVERDOSE |
10 |
0.0000 |
| 304 |
CONDITION AGGRAVATED |
14 |
0.0000 |
| 305 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 306 |
INTERSTITIAL LUNG DISEASE |
2 |
0.0000 |
| 307 |
LIVER INJURY |
1 |
0.0000 |
| 308 |
UNEVALUABLE EVENT |
3 |
0.0000 |
| 309 |
PHARMACEUTICAL PRODUCT COMPLAINT |
1 |
0.0000 |
| 310 |
JAUNDICE |
1 |
0.0000 |
| 311 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 312 |
PNEUMONITIS |
1 |
0.0000 |
| 313 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
2 |
0.0000 |
| 314 |
RESPIRATORY ARREST |
1 |
0.0000 |
| 315 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 316 |
ANAPHYLACTIC REACTION |
2 |
0.0000 |
| 317 |
MEDICATION ERROR |
2 |
0.0000 |
| 318 |
SEPSIS |
4 |
0.0000 |
| 319 |
INCORRECT DRUG ADMINISTRATION DURATION |
1 |
0.0000 |
| 320 |
INTERNATIONAL NORMALISED RATIO INCREASED |
1 |
0.0000 |
| 321 |
DRUG INEFFECTIVE |
46 |
0.0000 |
| 322 |
HEPATIC FAILURE |
1 |
0.0000 |
| 323 |
ACUTE KIDNEY INJURY |
5 |
0.0000 |
| 324 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
| 325 |
PRODUCT USE ISSUE |
6 |
0.0000 |
| 326 |
BLOOD PRESSURE DECREASED |
2 |
0.0000 |
| 327 |
SKIN DISORDER |
1 |
0.0000 |
| 328 |
HYPOTENSION |
6 |
0.0000 |
| 329 |
NEUTROPENIA |
4 |
0.0000 |
| 330 |
HYPERKALAEMIA |
1 |
0.0000 |
| 331 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 332 |
NO ADVERSE EVENT |
5 |
0.0000 |
| 333 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
1 |
0.0000 |
| 334 |
RESTLESSNESS |
1 |
0.0000 |
| 335 |
THROMBOCYTOPENIA |
3 |
0.0000 |
| 336 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
1 |
0.0000 |
| 337 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
5 |
0.0000 |
| 338 |
SEPTIC SHOCK |
1 |
0.0000 |
| 339 |
GASTROINTESTINAL DISORDER |
2 |
0.0000 |
| 340 |
PNEUMONIA |
7 |
0.0000 |
| 341 |
RENAL DISORDER |
1 |
0.0000 |
| 342 |
SWELLING |
2 |
0.0000 |
| 343 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 344 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 345 |
INFECTION |
3 |
0.0000 |
| 346 |
FLUID RETENTION |
1 |
0.0000 |
| 347 |
ERYTHEMA |
4 |
0.0000 |
| 348 |
BLISTER |
1 |
0.0000 |
| 349 |
DYSPNOEA |
10 |
0.0000 |
| 350 |
FLATULENCE |
1 |
0.0000 |
| 351 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 352 |
DEVICE MALFUNCTION |
1 |
0.0000 |
| 353 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 354 |
INCORRECT DOSE ADMINISTERED |
3 |
0.0000 |
| 355 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 356 |
DEATH |
11 |
0.0000 |
| 357 |
TREATMENT FAILURE |
1 |
0.0000 |
| 358 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 359 |
PRODUCT STORAGE ERROR |
1 |
0.0000 |
| 360 |
DRUG WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 361 |
TACHYCARDIA |
1 |
0.0000 |
| 362 |
DEVICE ISSUE |
1 |
0.0000 |
| 363 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 364 |
CARDIAC DISORDER |
1 |
0.0000 |
| 365 |
ANAEMIA |
2 |
0.0000 |
| 366 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 367 |
HEART RATE INCREASED |
1 |
0.0000 |
| 368 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 369 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 370 |
HAEMORRHAGE |
1 |
0.0000 |
| 371 |
HYPERTENSION |
2 |
0.0000 |
| 372 |
PLATELET COUNT DECREASED |
1 |
0.0000 |
| 373 |
MALAISE |
4 |
0.0000 |
| 374 |
SEIZURE |
1 |
0.0000 |
| 375 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 376 |
RENAL FAILURE |
1 |
0.0000 |
| 377 |
DEHYDRATION |
1 |
0.0000 |
| 378 |
TREMOR |
1 |
0.0000 |
| 379 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 380 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 381 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 382 |
WEIGHT INCREASED |
1 |
0.0000 |
| 383 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 384 |
PYREXIA |
1 |
0.0000 |